Nixon Peabody Trust’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Sell
92,565
-2,140
-2% -$311K 0.96% 27
2026
Q1
$13.7M Sell
94,705
-3,425
-3% -$519K 1.09% 27
2025
Q4
$14.1M Sell
98,130
-859
-0.9% -$127K 1.06% 27
2025
Q3
$15.2M Sell
98,989
-752
-0.8% -$117K 1.11% 25
2025
Q2
$15.9M Sell
99,741
-444
-0.4% -$72.5K 1.23% 26
2025
Q1
$17.1M Sell
100,185
-664
-0.7% -$111K 1.45% 19
2024
Q4
$16.9M Buy
100,849
+853
+0.9% +$145K 1.39% 23
2024
Q3
$17.3M Buy
99,996
+679
+0.7% +$115K 1.44% 23
2024
Q2
$16.4M Sell
99,317
-2,900
-3% -$474K 1.46% 21
2024
Q1
$16.6M Buy
102,217
+3,857
+4% +$605K 1.52% 22
2023
Q4
$14.4M Buy
98,360
+84,474
+608% +$12.5M 1.62% 23
2023
Q3
$2.03M Buy
13,886
+100
+0.7% +$15.3K 1.7% 27
2023
Q2
$2.09M Sell
13,786
-289
-2% -$43.6K 1.7% 20
2023
Q1
$2.09M Sell
14,075
-2,229
-14% -$319K 1.46% 31
2022
Q4
$2.47M Sell
16,304
-70
-0.4% -$9.81K 2% 14
2022
Q3
$2.07M Sell
16,374
-12,850
-44% -$1.83M 1.75% 18
2022
Q2
$4.2M Sell
29,224
-2,634
-8% -$396K 1.9% 16
2022
Q1
$4.87M Sell
31,858
-4,687
-13% -$733K 1.68% 21
2021
Q4
$5.98M Buy
36,545
+2,477
+7% +$368K 1.81% 19
2021
Q3
$4.76M Buy
34,068
+1,339
+4% +$190K 1.72% 25
2021
Q2
$4.42M Buy
32,729
+82
+0.3% +$11.1K 1.7% 28
2021
Q1
$4.42M Buy
32,647
+270
+0.8% +$35.2K 1.79% 24
2020
Q4
$4.5M Sell
32,377
-933
-3% -$130K 1.9% 21
2020
Q3
$4.63M Buy
33,310
+317
+1% +$42.1K 2.13% 16
2020
Q2
$3.94M Buy
32,993
+390
+1% +$45.5K 2% 18
2020
Q1
$3.59M Buy
32,603
+914
+3% +$110K 2.22% 14
2019
Q4
$3.96M Buy
31,689
+172
+0.5% +$21K 1.97% 22
2019
Q3
$3.92M Sell
31,517
-2,235
-7% -$264K 2.09% 18
2019
Q2
$3.7M Buy
33,752
+4,720
+16% +$503K 2.09% 20
2019
Q1
$3.02M Buy
29,032
+2,098
+8% +$204K 1.98% 25
2018
Q4
$2.48M Buy
26,934
+541
+2% +$48.4K 1.95% 23
2018
Q3
$2.2M Buy
26,393
+1,895
+8% +$155K 1.5% 34
2018
Q2
$1.91M Buy
24,498
+2,724
+13% +$205K 1.48% 34
2018
Q1
$1.73M Buy
21,774
+395
+2% +$32.9K 1.55% 34
2017
Q4
$1.97M Buy
21,379
+241
+1% +$21.7K 1.69% 32
2017
Q3
$1.92M Buy
21,138
+30
+0.1% +$2.73K 1.75% 30
2017
Q2
$1.84M Sell
21,108
-445
-2% -$39.2K 1.7% 30
2017
Q1
$1.94M Sell
21,553
-855
-4% -$75.8K 1.82% 25
2016
Q4
$1.88M Sell
22,408
-365
-2% -$31.1K 1.83% 26
2016
Q3
$2.04M Sell
22,773
-5,143
-18% -$447K 2.01% 19
2016
Q2
$2.36M Sell
27,916
-273
-1% -$22.4K 2.05% 14
2016
Q1
$2.32M Sell
28,189
-385
-1% -$31K 2.06% 14
2015
Q4
$2.27M Buy
+28,574
New +$2.18M 2.07% 14

Other funds holding PG

Nixon Peabody Trust's PG Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Procter & Gamble (PG) stake by 2.3% in Q2 2026, selling an estimated $311K and leaving 92,565 shares worth $13.6M. The position accounts for 0.96% of the portfolio, ranked #27.

Nixon Peabody Trust first reported a position in PG in Q4 2015 and has held it in 43 quarters since. The position peaked at $17.3M in Q3 2024. 1,650 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Nixon Peabody Trust held 92,565 shares of Procter & Gamble worth $13.6M as of Q2 2026.
  • Nixon Peabody Trust sold 2,140 Procter & Gamble shares in Q2 2026, an estimated $311K.
  • Procter & Gamble made up 0.96% of Nixon Peabody Trust's portfolio in Q2 2026, its #27 holding.
  • Nixon Peabody Trust first reported a position in Procter & Gamble in Q4 2015 and has held it in 43 quarters since.
  • Nixon Peabody Trust's Procter & Gamble position peaked at $17.3M in Q3 2024.
  • 1,650 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.